P3-092 O-T02B-1006
Biomaterials processing and biofabrication -
Bioprinting and bionik
Methacrylated hyaluronic acid and periosteum-derived cell spheroid bioink towards subchondral bone tissue engineering through the endochondral ossification pathway
Ane Albillos
|
P3-093 O-T02B-0895
Biomaterials processing and biofabrication -
Bioprinting and bionik
Embedded 3D bioprinting of collagen inks into microgel baths to control hydrogel microstructure and cell phenotype
Lucia Brunel
|
P3-094 O-T02B-0872
Biomaterials processing and biofabrication -
Bioprinting and bionik
Microfluidic bioprinting of hiPSC-derived progenitors to produce renal organoids
Gabriele Addario
|
P3-095 E-T02B-3304
Biomaterials processing and biofabrication -
Bioprinting and bionik
Optimizing extrusion bioprinting with decellularized ECM bioinks: a comprehensive rheological approach for bridging material properties to extrusion dynamics and thixotropy
Soham Ghosh
|
P3-096 E-T02B-3012
Biomaterials processing and biofabrication -
Bioprinting and bionik
Precision Biofabrication for Meniscal Tissue Engineering: Leveraging MEW and Microvalve Bioprinting to enable tunable Mechanical and Cellular Gradients.
Fraser Shields
|
P3-097 O-T02B-1541
Biomaterials processing and biofabrication -
Bioprinting and bionik
Development of a one-step process for pure collagen scaffold bioprinting
Sara Palladino
|
P3-098 E-T02B-1395
Biomaterials processing and biofabrication -
Bioprinting and bionik
Tunable GelMA Hydrogel of room-temperature Extrusion Bioprinting of C2C12 cellular scaffolds
Zaimao Peng
|
P3-099 E-T02B-0922
Biomaterials processing and biofabrication -
Bioprinting and bionik
Development of photo-click alginate hydrogels for tissue engineering and biofabrication
Matthew Mail
|
P3-100 O-T02B-0367
Biomaterials processing and biofabrication -
Bioprinting and bionik
Flexink - a new PEG-tyramine-based material for coaxial printing of small-diameter vessels
Julia Siminska-Stanny
|
P3-101 O-T02B-0545
Biomaterials processing and biofabrication -
Bioprinting and bionik
Biofabrication and Biophysical Characterization of Printed S. Typhimurium Biofilms
Annie Scutte
|
P3-102 E-T02B-1648
Biomaterials processing and biofabrication -
Bioprinting and bionik
Unveiling the relation between mechanical properties, cytocompatibility, and printability of decellularized extracellular matrix bioinks
Linglu Hong
|
P3-103 E-T02B-1080
Biomaterials processing and biofabrication -
Bioprinting and bionik
Encouraging vascular network formation in a 3D printed nipple-areola complex for post-mastectomy nipple reconstruction
Amal Shabazz
|
P3-104 P-T02B-3685
Biomaterials processing and biofabrication -
Bioprinting and bionik
A volumetric approach to mimic the osteoid niche
Edward Vermeersch
|
P3-105 O-T02B-1246
Biomaterials processing and biofabrication -
Bioprinting and bionik
Visible Light-Based 4D-Bioprinted Tissue Scaffold
Sriram Bharath Gugulothu
|
P3-106 E-T02B-3629
Biomaterials processing and biofabrication -
Bioprinting and bionik
A novel bioink to create vascularized structures harnessing microfluidic bioprinting
Efsun Senturk
|
P3-107 P-T02B-3736
Biomaterials processing and biofabrication -
Bioprinting and bionik
Development of Alginate-Based Bioinks to Model Prostate Cancer in vitro
khalsa alhusaini
|
P3-108 P-T02B-3562
Biomaterials processing and biofabrication -
Bioprinting and bionik
3D-bioprinted liver tissue model for testing the activity and cytotoxicity of drugs - revolution in preclinical testing of oncological drugs
Marta Klak
|
P3-109 P-T02B-3389
Biomaterials processing and biofabrication -
Bioprinting and bionik
Effect of crosslinking agents in bioinks on corneal cell viability
Li Jiang
|
P3-110 E-T02B-2847
Biomaterials processing and biofabrication -
Bioprinting and bionik
Engineering Biointeractive Biomaterials and Therapeutics Technologies for Biomedical Applications
Sohyung Lee
|
P3-111 P-T03D-3934
Biomaterials for theranostics -
Exosome and extracellular vesicle
RGD and Hep II domains on the surface of MSCs-derived extracellular vesicles for the differentiation of hiPSCs into MSCs
Jiseong Kim
|
P3-112 P-T03C-4035
Biomaterials for theranostics -
Drug delivery
Engineered chemothermal magnetic nanoparticles: Drug release and kinetics models from thermoresponsive polymeric gates coated SPIONs for cancer therapy
Abdelrahman I. Rezk
|
P3-113 P-T03D-3861
Biomaterials for theranostics -
Exosome and extracellular vesicle
Engineered Nanovesicles for Theranostics in Atherosclerosis
Jeong-Kee Yoon
|
P3-114 P-T03F-3375
Biomaterials for theranostics -
Immunomodulatory biomaterials
Oral delivery of bilirubin nanoparticles ameliorates non-alcoholic steatohepatitis
Afia Tasnim Rahman
|
P3-115 E-T03D-0939
Biomaterials for theranostics -
Exosome and extracellular vesicle
Scaling up the production of functional MSC-derived exosomes to facilitate cartilage tissue regeneration using a 3D culture system with microparticles
Hyoeun Park
|
P3-116 P-T03E-2381
Biomaterials for theranostics -
Gene therapy
Design of PD-L1-targeted lipid nanoparticles to turn on PTEN for efficient cancer immunotherapy
Yelee Kim
|
P3-117 P-T03D-2778
Biomaterials for theranostics -
Exosome and extracellular vesicle
Enhancing Oral Bioavailability of Peptide-Conjugated Antitumor Prodrugs with Milk-Derived Exosomes
Hochung Jang
|
P3-118 P-T03D-2129
Biomaterials for theranostics -
Exosome and extracellular vesicle
Functionalized extracellular vesicles elevate neuronal differentiation of neural progenitor cell
So-yeon Park
|
P3-119 P-T03D-2028
Biomaterials for theranostics -
Exosome and extracellular vesicle
Enhancing the secretion and functionality of extracellular vesicles (EVs) with 3D culture and stimulations of cells in chemically defined media
Jun Yong Kim
|
P3-120 P-T03D-2681
Biomaterials for theranostics -
Exosome and extracellular vesicle
3D modeling-guided cyclization of tagged proteins for efficient delivery into cells and extracellular vesicles
Yeonju Lee
|
P3-121 P-T03F-2410
Biomaterials for theranostics -
Immunomodulatory biomaterials
Enhancement of treatment for HER2-positive cancer using cell surface engineering system based on antibody-binding fusion protein
Chaeseon Kim
|